Pfizer Denied Interlocutory Appeal In Pay-For-Delay MDL

Pfizer Denied Interlocutory Appeal In Pay-For-Delay MDL

A Tennessee federal judge Tuesday rejected a bid by Pfizer Inc.'s King Pharmaceuticals LLC and Mutual Pharmaceutical Co. to appeal his finding that antitrust claims accusing them of blocking the release of a generic version of the drug Skelaxin were ...read more

  • Tags: